Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR
Genre
Journal articleDate
2015-09-22Author
Gabitova, LinaraRestifo, Diana

Gorin, Andrey
Manocha, Kunal
Handorf, Elizabeth A.
Yang, Dong-Hua
Cai, Kathy Q.
Klein-Szanto, Andres

Cunningham, David
Kratz, Lisa E.
Herman, Gail E.
Golemis, Erica

Astsaturov, Igor

Group
Fox Chase Cancer Center (Temple University)Department
Cancer and Cellular BiologyPermanent link to this record
http://hdl.handle.net/20.500.12613/9187
Metadata
Show full item recordDOI
http://dx.doi.org/10.1016/j.celrep.2015.08.023Abstract
Meiosis-activating sterols (MAS) are substrates of SC4MOL and NSDHL in the cholesterol pathway and are important for normal organismal development. Oncogenic transformation by epidermal growth factor receptor (EGFR) or RAS increases the demand for cholesterol, suggesting a possibility for metabolic interference. To test this idea in vivo, we ablated Nsdhl in adult keratinocytes expressing KRASG12D. Strikingly, Nsdhl inactivation antagonized the growth of skin tumors while having little effect on normal skin. Loss of Nsdhl induced the expression of ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, reduced the expression of low-density lipoprotein receptor (LDLR), decreased intracellular cholesterol, and was dependent on the liver X receptor (LXR) α. Importantly, EGFR signaling opposed LXRα effects on cholesterol homeostasis, whereas an EGFR inhibitor synergized with LXRα agonists in killing cancer cells. Inhibition of SC4MOL or NSDHL, or activation of LXRα by sterol metabolites, can be an effective strategy against carcinomas with activated EGFR-KRAS signaling.Citation
Gabitova L, Restifo D, Gorin A, Manocha K, Handorf EA, Yang D-H, et al. Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR. Cell Rep. 2015 Sep 22;12(11):1927-1938. doi:10.1016/j.celrep.2015.08.023.Citation to related work
Cell PressHas part
Cell Reports, Vol. 12, Iss. 11ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduCollections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND